Chromogranin A
Also known as: CgA
What Does Chromogranin A Measure?
Chromogranin A (CgA) is a protein produced and secreted by neuroendocrine cells throughout the body, including those in the adrenal glands, pituitary gland, thyroid, parathyroid, pancreas, and gastrointestinal tract. A blood test measuring CgA levels reflects how actively these specialized cells are functioning or, in disease states, how aggressively neuroendocrine tumors (NETs) may be growing and spreading. The test detects the concentration of this protein circulating in the bloodstream, typically reported in nanograms per milliliter (ng/mL) or units per liter (U/L) depending on the laboratory assay used.
Why Does Chromogranin A Matter?
CgA is one of the most clinically important tumor markers for neuroendocrine tumors (NETs), a diverse group of cancers that can arise almost anywhere in the body. Elevated CgA levels can help diagnose NETs, assess tumor burden, monitor response to treatment, and detect recurrence after surgery or other therapies. Because NETs are often slow-growing and can be difficult to detect on imaging alone, a rising CgA level may be among the earliest signs of disease progression. Beyond oncology, CgA elevations can also reflect heart failure, inflammatory conditions, and other disorders, making it a marker with broad clinical relevance for assessing neuroendocrine system activity.
Normal Ranges
Males
< 93 ng/mL (or < 76 U/L depending on assay; reference ranges vary significantly by laboratory and method)
Females
< 76 ng/mL (or < 60 U/L depending on assay; reference ranges vary significantly by laboratory and method)
Children
Varies by age; generally lower than adult values; consult laboratory-specific pediatric reference ranges
Causes of High Levels
- Neuroendocrine tumors (NETs) such as carcinoid tumors, pancreatic NETs, pheochromocytoma, and small cell lung cancer
- Proton pump inhibitor (PPI) use — medications like omeprazole and pantoprazole stimulate gastric enterochromaffin-like cells, causing false elevations
- Chronic atrophic gastritis and Helicobacter pylori infection, which increase gastrin-driven stimulation of neuroendocrine cells
- Chronic kidney disease or renal failure, which reduces CgA clearance from the bloodstream
- Heart failure and cardiovascular disease, as cardiac stress activates neuroendocrine pathways
- Inflammatory bowel disease, liver cirrhosis, and other chronic inflammatory or organ dysfunction conditions
Causes of Low Levels
- Successful surgical resection of a neuroendocrine tumor, leading to normalization of CgA
- Effective medical treatment of NETs (e.g., somatostatin analogs, targeted therapies) reducing tumor secretion
How to Improve Your Chromogranin A
Diet
- Follow a low-acid, nutrient-dense diet to support gastrointestinal health and reduce unnecessary stimulation of gastric neuroendocrine cells
- Limit alcohol intake, as alcohol can irritate the gastrointestinal tract and promote chronic inflammation that elevates CgA
- Incorporate anti-inflammatory foods rich in omega-3 fatty acids (fatty fish, flaxseed, walnuts) to reduce systemic inflammation
- Eat smaller, more frequent meals to reduce gastric acid secretion and minimize stimulation of enterochromaffin-like cells
- Ensure adequate protein intake from lean sources to support overall tissue health without excessive gastric stimulation
Supplements
- Consult a physician before taking any supplements, as some (e.g., high-dose vitamin C or herbal products) may interact with NET treatments
- Probiotics (Lactobacillus and Bifidobacterium strains, 10–50 billion CFU/day) may support gastrointestinal health and reduce H. pylori-associated CgA elevation
- Vitamin D3 (1,000–2,000 IU/day) to support immune function and reduce inflammation, after checking baseline levels
- Omega-3 fish oil (1–3 g/day of EPA+DHA) to support cardiovascular and anti-inflammatory health in patients with elevated CgA due to heart failure
Related Biomarkers
Frequently Asked Questions
What does it mean if my Chromogranin A is elevated?
An elevated CgA level does not automatically mean you have cancer. While high CgA is associated with neuroendocrine tumors, it can also be raised by common medications like proton pump inhibitors (antacids such as omeprazole), kidney disease, heart failure, chronic gastritis, and inflammatory conditions. Your doctor will interpret the result alongside your symptoms, medical history, imaging studies, and other tests before drawing any conclusions. A single elevated result should always be confirmed with repeat testing under standardized conditions.
Can proton pump inhibitors (PPIs) affect my CgA test result?
Yes, PPIs are one of the most common causes of falsely elevated CgA levels. These medications suppress stomach acid, which triggers a compensatory rise in gastrin, which in turn stimulates enterochromaffin-like cells in the stomach to produce more CgA. To get an accurate CgA measurement, most guidelines recommend stopping PPIs for at least 2 weeks before testing. However, never stop a prescribed medication without first consulting your doctor, as this needs to be done safely under medical supervision.
How is Chromogranin A used to monitor neuroendocrine tumors?
In patients with a confirmed NET, CgA is measured regularly — typically every 3 to 6 months — to track disease activity. A rising CgA trend may indicate tumor growth or spread before changes are visible on imaging scans. Conversely, a falling CgA level after treatment (surgery, somatostatin analogs, or chemotherapy) suggests a positive response. Because CgA correlates with tumor burden in many NETs, it provides a practical, non-invasive tool for long-term monitoring. However, not all NETs secrete CgA, so its usefulness varies by tumor type.